# Munich Re (MUV2) Q3 2026 earnings

Results filed 2026-11-12 for the quarter ended 2026-09-30. Source page: https://earnings.opennash.com/companies/munich-re/2026-q3/
Press release and documents: https://www.munichre.com/en/company/investors/reports-and-presentations/results-reports.html
> Summaries and transcripts are machine-generated and can contain errors.

## In brief

Munich Re grew fastest in life and health reinsurance and ERGO, while property-casualty reinsurance shrank as management walked away from business that misses its return requirements.

Life and health reinsurance expanded in all key regions, led by North America, the UK and Asia, helped by transactional deals in Q3. ERGO grew through its NEXT Insurance acquisition, the first-time inclusion of ADB Gjensidige and ERGO China Life Insurance, and strong German business. Property-casualty reinsurance shrank, with management citing rate reductions, business that misses its return requirements and less proportional business.
Management is steering toward more diversified, less volatile earnings under Ambition 2030, deploying capital through profitable growth and selective M&A. The main tension is pricing: management expects continued downward price pressure in property-casualty reinsurance, so growth elsewhere has to offset a shrinking book there. ERGO also carries a commitment to break-even in a business by the end of next year.

## Key numbers

| Metric | Value | Change | Basis |
| --- | --- | --- | --- |
| Insurance revenue (Q3) | €16,626m | up from €14,575m a year ago |  |
| Net result (Q3) | €1,742m | down from €1,997m a year ago |  |
| Operating result (Q3) | €2,472m | down from €3,036m a year ago |  |
| Net result (Q1–3) | €5,667m | up from €5,176m a year ago |  |
| Solvency II ratio | 301% | 31 December 2025: 298% |  |
| Annualised return on equity (Q3) | 20.2% | down from 24.2% a year ago |  |

## Segments and operating metrics

| Name | Value | Change |
| --- | --- | --- |
| Life and health reinsurance – insurance revenue | €3,769m | up from €2,868m a year ago |
| Life and health reinsurance – total technical result | €493m | up from €314m a year ago |
| Property-casualty reinsurance – combined ratio | 80.0% | from 62.7% a year ago |
| Global Specialty Insurance – combined ratio | 83.9% | from 82.8% a year ago |
| ERGO – insurance revenue | €6,192m | up from €5,313m a year ago |
| ERGO – net result | €263m | down from €304m a year ago |
| ERGO Germany P&C – combined ratio | 89.8% | from 88.7% a year ago |

## Outlook

| Metric | Period | Outlook |
| --- | --- | --- |
| Group net result target | 2026 | €6.6bn |
| Net combined ratio, property-casualty reinsurance | 2026 | less than 80% |
| Net combined ratio, Global Specialty Insurance | 2026 | less than 90% |
| Group insurance revenue | 2026 | ~€62bn |

## Key takeaways

1. **Life and health reinsurance grew in every key region** Insurance revenue rose to €3,769m from €2,868m, led by North America, the UK and Asia, and included transactional deals in Q3. New business CSM added (€1,475m) was well above the CSM released into earnings, which supports future growth.
2. **Property-casualty reinsurance is shrinking by design** Nine-month revenue fell 9.0% organically, driven by rate reductions, business that does not meet return requirements and lower shares in proportional business. Management is prioritising returns over volume as prices soften.
3. **Acquisitions reshaped ERGO International** ERGO NEXT Insurance, ADB Gjensidige and ERGO China Life Insurance now contribute to international growth. ERGO International revenue rose 15.6% over nine months, with the Baltic states and the USA among the added contributors.
4. **Specialty insurance is growing organically at HSB, AMIG and Specialty Global Markets** Global Specialty Insurance showed organic growth, though reported revenue was slightly lower because of USD depreciation, with FX-adjusted revenue up 2.3%. It remains a growth area outside the volatile reinsurance cycle.
5. **Guidance raised, with the P&C reinsurance combined ratio target now below 80%** The profit target rose from €6.3bn to €6.6bn and the combined-ratio targets for property-casualty reinsurance and Global Specialty Insurance were tightened. Management noted that the normalised property-casualty reinsurance combined ratio of 82.4% reflects recent renewals and business mix.

## Questions

**Where is Munich Re growing fastest?** Life and health reinsurance, where revenue rose to €3,769m from €2,868m with growth in all key regions, particularly North America, the UK and Asia. ERGO International also grew 15.6% over nine months, helped by acquisitions and first-time consolidations.
**Why is property-casualty reinsurance revenue falling?** Management points to reductions in rates, business that does not meet its return requirements, and lower shares in proportional business. Currency effects also contributed.
**What acquisitions are affecting ERGO?** ERGO NEXT Insurance is now fully owned, and ADB Gjensidige and ERGO China Life Insurance were consolidated for the first time, the latter as of Q3 2026. ERGO International also lost business in Spain health from the discontinuation of the MUFACE contract.
**What is Munich Re's strategic direction?** Its Ambition 2030 strategy emphasises broad diversification of earnings drivers, with growth in less volatile segments such as life and health reinsurance. Management says it aims to deploy capital through profitable business growth and selective M&A.
**What is the pricing outlook in reinsurance?** Management expects downward price pressure to continue, with loss-free portfolios more likely to see further price reductions than loss-affected ones. Normalised property-casualty reinsurance combined ratio of 82.4% reflects recent renewals and business mix.

## Slides and investor documents

- [IR presentation Q3 2026](https://www.munichre.com/content/dam/munichre/mrwebsiteslaunches/2026-q3/MunichRe-Presentation-IR-Q3-2026_EN.pdf/_jcr_content/renditions/original./MunichRe-Presentation-IR-Q3-2026_EN.pdf) (Slide deck)

